跳至主要内容
临床试验/IRCT20220410054474N1
IRCT20220410054474N1已完成3 期

Evaluating the effects of the traditional wheat product (saviq) on the pattern of changes caused bychemotherapy in the gastrointestinal tract of children with acute lymphoblastic leukemia referred to the Imam Rezaclinic in 1401 - a triple-blind clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 years 至 18 years(—)
性别
All

入选标准

  • Children aged 3-18 years with severe lymphoblastic leukemia treated in the post-consolidation period.

排除标准

  • Severely ill patients
  • Patients who must be prescribed fasting by physician
  • Patients with broad-spectrum antibiotics
  • Patients with active infection
  • Patients with celiac disease
  • Those requiring gastrointestinal surgery
  • Neutropenic patients

研究者

相似试验